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BrainMitochondria dysfunction contributes to the pathophysiology of obesity, diabetes, neurodegeneration and
ageing. The peroxisome proliferator-activated receptor-gamma coactivator-1β (PGC-1β) coordinates mito-
chondrial biogenesis and function as well as fatty acid metabolism. It has been suggested that endoplasmic
reticulum (ER) stress may be one of the mechanisms linking mitochondrial dysfunction and these patholo-
gies. Here we investigate whether PGC-1β ablation affects the ER stress response induced by speciﬁc nutri-
tional and pharmacological challenges in the CNS. By using ﬂow cytometry, western blot, real time PCR
and several pharmacological and nutritional interventions in PGC-1β knock out and WT mice, we conﬁrmed
that PGC-1β coordinates mitochondria function in brain and reported for the ﬁrst time that a) ablation of
PGC-1β is associated with constitutive activation of mTORC1 pathway associated with increased basal
GRP78 protein levels in hypothalamus and cortex of animals fed chow diet; and b) in animals fed chronically
with high fat diet (HFD) or high protein diet (HPD), we observed a failure to appropriately induce ER stress
response in the absence of PGC-1β, associated with an increase in mTOR pathway phosphorylation. This
contrasted with the appropriate upregulation of ER stress response observed in wild type littermates. Addi-
tionally, inefﬁcient in vitro induction of ER stress by thapsigargin seems result in apoptotic neuronal cell
death in PGC-1β KO. Our data indicate that PGC-1β is required for a neuronal ER response to nutritional stress
imposed by HFD and HPD diets and that genetic ablation of PGC-1βmight increase the susceptibility to neu-
ronal damage and cell death.
Published by Elsevier Inc. Open access under CC BY license.Introduction
Maintenance of energy homeostasis is coordinated by the crosstalk
between peripheral organs and the central nervous system and more
speciﬁcally the hypothalamus (Stefater and Seeley, 2010). Glucose,
lipids and amino acids are metabolized in themitochondria and defects
in mitochondrial function may contribute to nutrient overload causing
cellular damage as typically associated with obesity, insulin resistance,
cardiovascular disease, neurodegeneration or accelerated ageing
(Mattson et al., 2008, Patti and Corvera, 2010).
Peroxisome-proliferator-activated-receptor γ coactivator 1 beta
(PGC-1β) regulates mitochondrial biogenesis and function through
its coactivating effects on speciﬁc nuclear receptors (Tseng, et al.,uímica. Universidad Nacional
+44 1223 336855.
il.com (A. Camacho).
70721 44007 Nantes Cedex 1,
C BY license. 2010). PGC-1β is highly expressed in pro-oxidative tissues such as
heart, skeletal muscle, and brown fat but also in the brain (Lin, et
al., 2002, Meirhaeghe, et al., 2003). There is evidence that PGC-1β
genetic ablation results in defective mitochondrial activity leading to
defects in thermogenesis, hepatic function, and cardiac performance
(Lelliott, et al., 2006, 2007, Sonoda, et al., 2007). Of note, the PGC-1β
KO mice are viable and apparently metabolically healthy when fed a
chow diet, however, when challenged with an acute load of high fat
diet (HFD), they develop liver steatosis (Lelliott, et al., 2006, Sonoda,
et al., 2007), suggesting that PGC-1β is required for the appropriate
regulation of lipid metabolism, particularly under stressful metabolic
conditions (Lelliott, et al., 2006, Sonoda, et al., 2007).
Mammalian target of rapamycin (mTOR) core is a serine/threonine
kinase comprised of two distinct protein complexes referred to as
TORC1 and TORC2 (Howell and Manning). TORC1 complex is composed
of the mTOR, mLST8, raptor and deptor, and its main function is to sense
changes in amino acids, glucose and oxygen availabilitywhile promoting
adaptive cell growth responses mediated by phosphorylation of 4E-BP1
and S6K1/2 proteins (Zoncu, et al.). It has recently been demonstrated
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motingmTORC1 activation (Inoki, et al., 2003, Kim, et al., 2002). Interest-
ingly, mTORC1 activates basal mitochondrial function and biogenesis
(Cunningham, et al., 2007, Schieke, et al., 2006), whereas its disruption
may result in cell damage in many disorders (Bentzinger, et al., 2008,
Risson, et al., 2009). However, chronic mTORC1 activation may lead to
metabolic derangements and pathologic states (Weichhart, 2012). Of
note, mTORC1 is physically associated with the mitochondria through
the FKBP12-rapamycin associated protein (FRAP) (Desai, et al., 2002);
however, there is little knowledge about the molecular mechanism in-
volved in such interaction and its cellular effects during chronic
mTORC1 stimulation. Of interest, mTOR may also activate endoplasmic
reticulum (ER) stress response (Di Nardo, et al., 2009, Ozcan, et al.,
2008) and indeed its activation has been demonstrated in several disor-
ders such as diabetes, cardiovascular disease, cancer, neurodegeneration
and aging (Tsang, et al., 2007, Zoncu, et al., 2011). This suggests that
mTOR may be a functional node linking mitochondrial dysfunction and
ER stress susceptibility and thus inﬂuencing the development of meta-
bolic disturbances. However, it is unclear whether this may be the
cause or consequence of mitochondrial dysfunction.
Here we investigate the link between defects in mitochondria
function induced by PGC-1β ablation, the activation of mTORC1 and
the induction of an ER stress response. Moreover, we investigated
whether under speciﬁc nutritional stressors such as HFD and/or
high protein diet (HPD), the absence of PGC-1β results in increased
vulnerability to neuronal death.
Materials and methods
Animal models
All the experimentswere performed usingwild-type andPGC-1βKO
on a C57BL/6 background generated as previously reported (Lelliott, et
al., 2006). Animal procedures were performed in accordance with the
UK Home Ofﬁce regulations and the UK Animal Scientiﬁc Procedures
Act [A(sp)A 1986. Animals were housed in a temperature-controlled
room with a 12-h light/dark cycle. Food and water were available ad
libitum.
Immunoblotting
Brain regions (including hypothalamus and cortex) were dissected
and homogenized in lysis buffer as described (Camacho, et al., 2007).
Immunoblottingwas performed following the protocol previously pub-
lished with minor modiﬁcations (Camacho, et al., 2007). The following
antibodies were used (Suppl. Fig. 1).
Mice, long-term feeding and treatments
Mice were placed on three different diets: 1) at weaning
(4-week-old) on normal chow diet (4.8% fat, 74.3% carbohydrates, and
16.8% protein with a total energy content of 4.07 kcal/g) (R3 diet,
Lactamin AB, Stockholm, Sweden); 2) at weaning (4-week-old) on
High Fat Diet (HFD, 45% fat, 35% carbohydrates and 20% protein, total
energy 4.73 kcal/g) (D12451, Research diets, New Jersey, USA) during
24 weeks; and 3) at 6 months on High Protein Diet (HPD) (4.3% fat,
48.1% carbohydrates, and 38.5% protein with a total energy content of
3.85 kcal/g) (D03091001, Research diets, New Jersey, USA) during
14 weeks.
In vivo ER stress induction
Wild-type and PGC-1β KO were given a single intraperitoneal
injection of 1 μg/g body weight of tunicamycin as previously reported
(Zhang and Kaufman, 2008). 24 h after the injection, the mice weresacriﬁced and the brain regions were processed for western blot or
real time PCR analysis as described below.
RNA extraction and real-time PCR
Brain tissues used for RNA extraction were prepared as previously
published (Lelliott, et al., 2005, Medina-Gomez, et al., 2005).
Real-time PCR was performed using a TaqMan 7900 (Applied
Biosystems, http://www.appliedbiosystems.com) according to stan-
dard protocols. Primers and TaqMan probes were designed using
Primer Express, version 2.0 (Applied Biosystems). Primer and probe
sequences are shown in (Suppl. Fig. 2).
Immunohistochemistry
To characterize the hypothalamic nucleus speciﬁc GRP78 expres-
sion, we used an immunohistochemical approach with slight modiﬁ-
cations as previously described (Camacho, et al., 2007). Antibodies
used were primary mouse anti-GRP78 (1:200) and secondary Alexa
Fluor 568 donkey anti-mouse IgG (1:1000). Negative controls in-
volved incubating sections with primary or secondary antibodies
without the secondary or primary antibody with undetectable signal.
Sections were mounted with Vectashield (Vector Laboratories)
containing 4′,6-diamidino-2-phenylindole (DAPI) and were analyzed
by using an inverted ﬂuoresce microscope (ECLIPSE Ti, Nikon).
Neuronal culture
Cortical mouse neurons were cultured as described (Papadia, et
al., 2005). Cortex was dissected from embryonic E17 pups (1 cortex
per culture) in Neurobasal A medium supplemented with B27
(Invitrogen), 1% rat serum, and 1 mm glutamine (Invitrogen) and
cultured for 10–14 days as described (Papadia, et al., 2005). ER stress
activation was made in trophically deprived medium using
thapsigargin (0.5 μM in DMSO), tunicamicyn (4 μM in DMSO) and
palmitic acid (40 μM in NaOH 0.1 N) for 1, 3, 6, 12 and 24 h. When re-
quired, the role of amino acids on insulin sensitivity was addressed by
incubation with (5–500 μM) L-Leucine and 100 nM insulin and/or
50 nM rapamacyn. The effect of mTOR activation on ER stress was
evidenced by the stimulation with 0.5 μM thapsigargin and 50 nM
rapamacyn. After stimulation, cells were washed with cold phos-
phate‐buffered saline (PBS) and lysis (150 mM NaCl, 25 mM Tris–
HCl pH 7.4, 1% triton, protease inhibitors (04693159001, Roche, UK)
and phosphatase inhibitors (04906845001, Roche, UK)/or RLT
(RNeasy Mini Kit, Qiagen Ltd, Crawley, UK) buffer were added to per-
form immunoblot or RT-PCR analysis respectively.
Flow cytometry analysis of mitochondrial membrane potential
Freshhypothalamus fromWTandPGC-1βKOmicewereplaced on ice
containing PBS and chopped into small pieces, less than 1 mm using
blades. Tissue dissociation was performed using serum free Dulbecco's
Modiﬁed Eagle's Media (DMEM) containing 0.25% trypsin (≥6,000
units/mg protein) and incubated at 37 °C for 10 min. After incubation,
equal volumes of DMEM containing 10% foetal serum were added to the
reaction to disable the enzyme activity. Cell suspension was ﬁltered
through a 40 μM cell strainer, followed by 1500 rpm centrifugation for
5 min and the resulting pellet was resuspended in 1 ml of warm PBS.
1 million of hypothalamic cells from WT and PGC-1β mice were used
for each assay. To analyze the mitochondrial membrane potential we
used 5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-benzamidazolocarbocyanin
iodide (JC1,M34152Molecular Probes) following themanufacturer's pro-
tocol. This dye can selectively enter themitochondria, due to its positively
chargedmolecule, where it reversibly aggregates uponmembrane polar-
ization causing shifts in emitted light from 530 nm (monomeric form,
green ﬂuorescence) to 590 nm (J aggregate form ,red ﬂuorescence)
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tration) was added to each sample and incubated at 37 °C, 5% CO2 for
15 min. Mitochondrial membrane depolarization was performed by
adding 1 μl of 50 mM CCCP (50 μM ﬁnal concentration) to the cell sus-
pension for 5 min at 37 °C. In these conditions JC1 monomeric aggregate
in cytoplasm detected at 530 nm is the predominant form.Mitochondrial
membrane depolarization (JC1) was analyzed by ﬂow cytometry on a
FACS Calibur and analyzed by Cellquest Pro software (Becton and Dickin-
son, NJ, United States). The ratio between the ﬂuorescence at 530 nm
(monomeric form) to 590 nm (J aggregate form)was calculated as indic-
ative of the mitochondrial membrane depolarization. To adjust the basal
values we used hypothalamic neurons from WT mice. In the graph we
gave them a value=1 and we compared the fold of chance in the KO
neurons.
Lipid proﬁling
Tissue homogenates were prepared and lipids were extracted by
the method of Folch et al., 1957 (Folch, et al., 1957), and individual
species were measured by ESI-MS/MS using a PE Sciex API 3000 triple
quadrupole mass spectrometer. Concentrations are reported in pmol/
mg of total cell protein. Relative cholesterol levels are expressed as a
ratio of the 20 cholesteryl ester to the 17:0 cholesteryl ester internal
standards per mg of total cell protein. For PC and PG species, only
the total number of carbons and double bonds of the two fatty acids
are reported.
Gangliosides were puriﬁed from the aqueous layer using C18 clean
up extraction columns. Samples were analyzed on a PE Sciex API 3000
triple quadrupole mass spectrometer with an electrospray source.
Ganglioside concentrations were calculated by ratio against a
known amount of extracted deuterated ganglioside internal standard.
Values are semi-quantitative only. Concentrations are reported in
pmol/mg of the total cell protein loaded onto the sucrose gradient
for membrane raft isolation. TheMRM transition used for this analysis
cannot differentiate between C20:1/18:0 and C18:1/20:0. Further
fragmentation (i.e. MS3) is proposed in future work and will resolve
the species of ganglioside present. However, it has been reported in
a number of papers that the most prevalent species in the brain is
the C20:1/18:0 species and this is what we have temporarily assigned
(Whitﬁeld, et al., 2000), GM1 C18:1/18:0. GM2 and GM3 species have
been conﬁrmed by HPLC retention times.
Statistical analysis
Data analysis was performed using StatView Version 4.5 (Abacus
Concepts, Berkley, California, United States). Statistical differences be-
tween two groups were evaluated using the unpaired Student's t test.
Data are presented as mean±SEM. The signiﬁcance levels displayed
on ﬁgures are as follows: * indicates pb0.05.
Results
Ablation of PGC-1β leads to brain mitochondrial dysfunction and
constitutive activation of mTORC1 pathway
Gene expression analyses of hypothalamus from PGC-1β KO com-
pared to WT mice showed a signiﬁcant decrease in the levels of mito-
chondrial transcription factor A (TFAM), the voltage dependent anion
channel 1 (VDAC1) and mitofusin 2 (MFN2) genes encoding for pro-
teins related to mitochondrial differentiation and mitochondria abun-
dance and mitochondria fusion respectively (Mahad, et al., 2009,
Scarpulla, 2008) (Fig. 1A). No compensatory upregulation of PGC-1α
expression was observed in PGC-1β KO (Fig. 1A). We also observed
that hypothalamic neurons from PGC-1β KOmice showed lower mem-
brane potential (lower ΔΨm) than their WT counterparts and this was
evidenced by an increase in the JC1 monomeric form detected at530 nm, an effect that was consistent in untreated and CCCP treated
samples (Figs. 1B and C). Globally, these results suggest that PGC-1β
KO neurons may have less mitochondria, less functional mitochondria
or a combination of both.
Given that states characterised by impaired mitochondrial func-
tion have been shown to inhibit mTOR activation in 3 T3 cell line
and also beta cells (Dennis, et al., 2001, Desai, et al., 2002, Inoki, et
al., 2003, Kim, et al., 2002), we analyzed whether PGC-1β ablation
was associated with impaired mTORC1 activation by measuring phos-
phorylation of its effectors Thr 389 (S6K1), Ser65 (4EBP1) and Ser
235/236 (S6). Unexpectedly, our results showed that under basal
conditions, the absence of PGC-1β results in the constitutive activa-
tion of mTORC1 pathway in brain, as indicated by the increased phos-
phorylation of S6K1 (Thr 389) and 4EBP1 (Ser65), but not Ser 235/
236 in the hypothalamus of young-adult PGC-1β KO mice (Figs. 1D,
E). Of note, this increase in the basal levels of mTORC1 pathway acti-
vation correlated with the upregulation of GRP78 protein, a marker of
ER stress, in adult mice (Figs. 1D, E). Altogether, these data indicate
that ablation of PGC-1β results in a decrease in mitochondrial func-
tion, which associates with constitutive mTORC1 and ER stress activa-
tion in brain under basal conditions.
Deletion of PGC-1β leads to inefﬁcient induction of ER stress activation in
hypothalamus and cortex in response to High Fat Diet (HFD)
Similar to young-adult mice, we observed an increase in the pro-
tein levels of GRP78 in older PGC-1β KO mice (8 months old)
(Fig. 2A). This result suggests that activation of ER stress is character-
istic of ablation of PGC-1β at hypothalamic level. Importantly, immu-
noﬂuorescent staining and analysis of brains fromWT and PGC-1β KO
mice indicated that the upregulation of GRP78 in the KO mice is re-
stricted to the paraventricular nucleus (Fig. 2B), a hypothalamic re-
gion involved in the coordination of energy homeostasis through its
differential sympathetic output to target organs (Pyner, 2009). No
changes at gene expression level of GRP78 or additional ER stress
markers, such as CHOP, XBPs, and GADD34, were detected between
WT and KO when fed chow diet (Suppl. Fig. 3A), suggesting that the
basal ER stress activation observed in PGC-1β KO mouse is primary
regulated at post-transcriptional level.
It is well established that fatty acid overload induced by mitochon-
drial dysfunction and/or HFD feeding leads to ER stress in different cell
types (Hotamisligil, 2010). Firstly we analyzed if basal activation of ER
stress response correlateswith hypothalamic lipid accumulation related
to mitochondria dysfunction in the PGC-1β KOmodel. In particular, we
explored the role of ceramide species, as it has been demonstrated to
induce ER stress (Lang, et al., 2011). Lipid proﬁle of hypothalamic KO
mice showed no major changes in ceramides, glucosylceramides,
lactosylceramides, phosphoinositides, phosphotidylethanolamines,
sphingosine and cholesterol (Suppl. Data), suggesting that ER stress re-
sponse activation in PGC-1βKO is not related to ceramide accumulation
under basal conditions. Of interest, we found a speciﬁc reduction in gan-
gliosides species, GM1 (C18:1, 18:0; C20:1, 18:1; C16:1, 18:0) and GM2
(C18:1, 18:0; C20:1, 18:0) (Fig. 3A), which correlateswith defects in en-
zymes regulating this pathway, including B3gal5, B4gal6 and Hexa 1
(Fig. 3B). These results suggest a selective regulation of ganglioside
pathway in the brain of PGC-1β KO which may contribute to the ER
stress regulation, as we will discuss later.
Additionally, we found that WT fed HFD showed increased hypo-
thalamic GRP78 protein levels in comparison to chow fed WTs, but
not in the PGC-1β KO (Fig. 2A). These results suggest that the ablation
of PGC-1β prevented further HFD-induced ER stress response. Of note,
we also observed an increase in the protein levels of CHOP, a second ER
stress and apoptotic cell death marker; in hypothalamus of PGC-1β KO
mice fed HFD (Fig. 2A). At ﬁrst, the latter suggested that this inappro-
priate ER stress response may be associated with increased susceptibil-






Fig. 1. PGC1-β regulates brain mitochondria biogenesis and function. A) Hypothalamic gene expression of mitochondria markers from 8-week-old male WT and PGC1-β KO mice fed
chowdiet. Individualmeasurements are standardizedusing actin, and then the average of theWTgroupwas set to 1. (n=6–8). B–C)Hypothalamic neuronswere dissociated as described
and basal and stimulated mitochondria activity, using buffer or 1 μl of 50 mM CCCP, respectively, were performed and analyzed by ﬂow cytometry using Alexa Fluor 488 dye and
R-phycoerythrin ﬁlter. D) Western blot shows the speciﬁcity of mTOR core components on Chow diet in WT and PGC1-β KO mice. E) Densitometry analysis of blots for GRP78,
p4EBP1, pSer235/236 and Thr389were corrected against loading control actin, 4EBP1 or S6K1, respectively. Graphs show the normalized results of mean±SEM for n=6–8 and statistical
signiﬁcance after using unpaired Student's t test. *pb0.05.
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stress conditions was further conﬁrmed in vivo in animals treated intra-
peritoneally with one dose of tunicamycin, a pharmacological inducer
of ER stress for 24 h (Fig. 2C). Speciﬁcally, WT but no PGC-1β KO mice
treated with tunicamycin showed an increase in hypothalamic GRP78
protein levels as compared to their untreated group (Fig. 2C). We also
validated the increase gene expression of GRP78, XBPs, CHOP andGADD34 under this strong pharmacological stimulus in WT hypothala-
mus but not in PGC-1β KO mice (Suppl. Fig. 3B). Importantly, the ex-
pression level of PGC-1α mRNA, that normally compensated the lack
of PGC-1β in peripheral organs, was unchanged in the PGC-1β KO
brains (data not shown).
The pattern of hypothalamic dysregulation of GRP78 in PGC-1β KO






Fig. 2. Ablation of PGC1-β results in basal GRP78 expression but inefﬁcient ER stress response on a challenge. A)Western blot shows the speciﬁcity of GRP78 and CHOP on Chow and HFD
and their densitometry analysis (n=6–8). B) Hypothalamic co-immunostaining for GRP78 (red) and DAPI (blue) inWT and PGC1-β KOmice on Chow diet. C) Western blot shows the
speciﬁcity of hypothalamic GRP78 and CHOP before and after Tunicamicyn administration (n=6–8). D)Western blot shows the basal increase of GRP78 and inefﬁcient upregulation in
the cortex of PGC1-β KO under HFD, and basal GRP78 upregulation in an in vitro system of cortical neurons (n=6–8). Graphs show the normalized results of mean±SEM and statistical
signiﬁcance after using unpaired Student's t test. *pb0.05.
400 A. Camacho et al. / Experimental Neurology 237 (2012) 396–406to HFD stress was also reproducible in the cortex in vivo and also in cor-
tical neurons in vitro, respectively (Fig. 2D). All together, these results
suggest that different regions of the brain are equally sensitive to
metabolic disturbance associated to dysfunctional PGC-1β regarding
ER stress response.Inefﬁcient pharmacologically induced ER stress response in PGC-1β KO
mice seems to contribute to apoptotic neuronal death
The molecular mechanisms mediating the defective ER stress re-
sponse in the brains of PGC-1β KO mice under different stress
AB
Fig. 3. GM1 and GM2 gangliosides levels in the hypothalamus of WT and PG1beta KO mouse. Individual lipid species were measured as described in Materials and methods. Sta-
tistical analysis was performed by using a two tail ANOVA following by a post-hoc Bonferroni test. Values are mean 5 standard error of mean. *pb0.05 versus WT.
401A. Camacho et al. / Experimental Neurology 237 (2012) 396–406stimulus were further dissected in vitro. Mimicking our in vivo ﬁndings in
animals fed a HFD or pharmacologically treated with tunicamycin, in
vitro treatment of cultured neurons with the ER stress inducers
tunicamycin or palmitate caused an increase in GRP78 protein content
inwild type at 6 h but not at the samemagnitude as PGC-1β KO neurons,
when comparedwith its basal values (Fig. 4A). The antibody can also rec-
ognize GRP94 protein, which like GRP78 also has a KDEL sequence
(Figs. 4A, B, upper band). Of note, GRP94 protein levels correlate with
GRP78 upregulation in our experiments (Figs. 4A, B, upper band),
supporting the effect of inefﬁcient ER stress activation in PGC-1β KO neu-
rons. By using a third ER stress inductor, thapsigargin, which inhibits pro-
tein glycosylation and promotes protein accumulation in the ER, we also
found inefﬁcient GRP78 upregulation in hypothalamic neurons of
PGC-1β KO at 12 and 24 h after treatment (Fig. 4B). In terms of gene ex-
pression level, no differences in the transcriptional induction of GRP78,
CHOP, XBPs and GADD34 were found between WT and PGC-1β KO cul-
tured neurons after our protocol with thapsigargin or tunicamycintreatment (Suppl. Fig. 4). These results reinforce the concept that the in-
efﬁcient ER response in the PGC-1β KO is primarily coordinated at post
transcriptional level.
The discrepancy between the increase in the protein levels and no
changes in mRNA level at the basal state in the PGC-1β KO as com-
pared to WT model, could be due to differences in the IF2a phosphor-
ylation, as a candidate for post transcriptional regulation in the basal
state between genotypes. Early stages of the ER stress response are
characterized by phosphorylation of IF2a resulting in attenuation of
protein translation and speciﬁc synthesis of GRP78 as a strategy for
ER stress relief (Eizirik, et al., 2008). We found that the increase in
GRP78 protein levels in the cortical neurons of PGC-1β KO under
non‐stimulated basal conditions was associated with decreased IF2a
phosphorylation (Fig. 4B). Using the same antibody, we also found in-
creased GRP94 protein levels at the basal state and inefﬁcient
upregulation in PGC-1β KO under ER stress challenges, which corre-
lated with GRP78 levels (see Figs. 4A and B, upper band, palmitic
A B
C
Fig. 4. Inefﬁcient ER stress response in PGC1-β KO brain results in neuronal cell death. A) Neuronal culture was stimulated with tunicamycin or palmitic acid as described and protein
levels of GRP78 were analyzed by western blot. A representative western is shown. B) Neuronal culture was stimulated with thapsigargin as described and protein levels of GRP78
and pIF2α were analyzed. GRP78 and pIF2a were normalized using total actin and IF2a, respectively. C) Apoptotic markers such as Caspase 3 cleavage and PARP were analyzed after
thapsigargin stimulation. Graphs show the normalized results of mean±SEM for n=5 and statistical signiﬁcance after using unpaired Student's t test. *pb0.05.
402 A. Camacho et al. / Experimental Neurology 237 (2012) 396–406and tunicamycin experiment, respectively). Thus, this supported the
concept that absence of IF2a phosphorylation increased basal GRP78
levels in PGC-1β KO hypothalamic neurons, an effect that is
prevented by IF2a phosphorylation in WT.
Failure to appropriately induce ER stress markers may lead to cell
death (Szegezdi, et al., 2006). Hence, we addressed whether the inefﬁ-
cient ER stress response observed in PGC-1β KO neurons increased sus-
ceptibility to cellular damage. Stimulation of ER stress response by
thapsigargin increased two markers of apoptotic cell death, namely
cleaved caspase 3 and its target PARP to a greater extent in PGC-1β KO
than in WT neurons (Fig. 4C). Altogether, our data suggest that PGC-1β
is necessary for the complete activation of ER stress response and that
its inactivation seems to increase the susceptibility to neuronal damage
and cell death induced by nutritional and pharmacological ER stressors.Constitutive activation of mTORC1 pathway in PGC-1β KO brains
determines basal ER stress response
It is known that activation of mTOR pathway promotes ER stress
(Di Nardo, et al., 2009, Inoki, et al., 2011, Kato, et al., 2012, Ozcan, et
al., 2008). Thus, we investigated whether the basal ER stress activa-
tion observed in PGC-1β KO mice were associated to constitutive ac-
tivation of the mTOR pathway. Mimicking the in vivo studies, our in
vitro results indicated that PGC-1β KO neurons exhibited activation
of mTORC1 in the basal state as evidenced by increased phosphoryla-
tion of Thr 389 (S6K1), which correlated with basal upregulation of
GRP78 (Fig. 5A).
We next investigated whether nutritional activation of mTOR
pathway by branched chain amino acids resulted in differential
403A. Camacho et al. / Experimental Neurology 237 (2012) 396–406increase of ER stress markers between genotypes. Thus, in vitro acti-
vation of mTORC1 with small dose of L-leucine (5, 50 and 100 μM) in-
creased phosphorylation of Thr 389 (S6K1) and Ser 235/236 (S6) and
was associated with higher upregulation of GRP78 in PGC-1β KO neu-
rons vs. WT (Fig. 5A). However, at higher concentrations (250 and
500 μM) of branched chain amino acids, the upregulation effects on
mTOR and GRP78 caused by L-leucine were lost (Fig. 5A). A priori,
these data suggest that ER stress induction in PGC-1β KO is sensitive
to the activation by mTOR pathway, recapitulating the constitutive
activation of mTOR observed in PGC-1β KO under basal conditions.
However, in the context of a strong challenge with branched chain
amino acids, PGC-1β KO neurons are not able to further activate the
induction of ER stress.
In agreement with our in vivo model, cultured neurons in vitro
from PGC-1β KO showed increased GRP78 protein levels at the
basal state and this correlates with Thr 389 phosphorylation
(Figs. 5B, C). Activating ER stress response in vitro using thapsigargin
promoted higher increased Thr 389 (S6K1) phosphorylation and
GRP78 upregulation at 12 h in WT and to a lesser extent in PGC-1β
KO (Figs. 5B, C). This may suggest that the initial activation of ER
stress may also facilitate mTOR activation. Moreover, we also found
that during the time course of the ER stress response induced by
thapsigargin, PGC-1β KO neurons exhibited lower IF2a phosphoryla-
tion than in WT at 12 h (Figs. 5B, C). Finally, we showed that inhibi-
tion of mTOR pathway by rapamycin increased basal pIF2a
phosphorylation and decreased the upregulation of GRP78 proteinA
B
C
Fig. 5. Constitutive mTOR activation in PGC1-β KO model leads to GRP78 expression. A) Neu
western blot analysis for GRP78, pThr389 and pSer235/236 was performed. A representative
or DMSO during 1 or 12 h and protein levels for GRP78, pThr389 and pIF2a was analyzed as
before and during treatments was performed. Graphs show the normalized results of me
*pb0.05.levels previously induced by thapsigargin in WT and KO brains at
12 h (Figs. 5B, C). This indicates that mTORC1 pathway may also be
activated during ER stress induction in neurons. Together, our results
so far indicate that ablation of PGC-1β is associated with constitutive
activation of mTORC1 pathway and increased basal GRP78 expres-
sion, but that ablation of PGC-1β prevents a further activation of ER
stress response under nutritional and pharmacological stimulus.
HPD feeding promotes mTOR overactivation but inefﬁcient GRP78
expression in brain of PGC-1β KO mice
Next we investigated whether the differences in the activation of
mTOR pathway observed between KO and WT in vitro upon different
doses of L-leucine treatments were recapitulated in vivo. We investi-
gated the differential response to hyperproteic and chow diets with
respect to activation of mTOR and GRP78 in wild type and PGC-1β
KO mice. Our results showed that when fed chow diet, basal Thr
389 (S6K1) phosphorylation and GRP78 protein levels were increased
in hypothalamus and cortex of PGC-1β KO mice compared to wild
type brains (Figs. 6A, B). The treatment with HPD diet during
14 weeks increased mTORC1 activation, as indicated by increased
phosphorylation of Thr 389, similarly in the hypothalamus of both ge-
notypes (Fig. 6A). However, HPD only promoted upregulation of
GRP78 in WT but not in PGC-1β KO mice (Fig. 6A). Of note, HPD feed-
ing promoted mTORC1 activation and GRP78 upregulation in the cor-
tex of WT mice and inefﬁcient GRP78 upregulation in PGC-1β KOronal culture was stimulated with L-leucine (5, 50, 100, 250, 500 μM) during 12 h and
experiment from 3. B, C) Neuronal culture was stimulated with thapsigargin (0.5 μM)
described in Fig. 1. For some experiments preincubation with rapamacyn (50 nM) 1 h
an±SEM for n=3–4 and statistical signiﬁcance after using unpaired Student's t test.
BA
Fig. 6. HPD promotes brain mTOR over activation in PGC1-β KO mice. Western blot showing pThr389 and GRP78 expression after HPD feeding in the hypothalamus (A) and cortex
(B) of WT and PGC1-β KOmice, respectively. Densitometry analysis is shown below. Graphs show the normalized results of mean±SEM for n=6–8 and statistical signiﬁcance after
using unpaired Student's t test. *pb0.05.
404 A. Camacho et al. / Experimental Neurology 237 (2012) 396–406mice (Fig. 6B). These results suggest that PGC-1β KO is required to
mediate the ER stress response induced by nutritional stress via
mTOR in the CNS.
Discussion
Our results support a role of PGC-1β as a coordinator of the ex-
pression of mitochondrial function in the brain, in a similar way as
it has been reported in other organs such as liver, muscle (Lelliott,
et al., 2006, Sonoda, et al., 2007) and also in neurons in vitro
(Wareski, et al., 2009). Of note, while mitochondria dysfunction is
present in PGC-1β KO neurons under non‐stimulated basal condi-
tions, this is not associated with a wide alteration in lipid species
composition including ER stress precursor ceramides. These results
suggest that basal ER stress response activation in hypothalamus of
PGC-1β KO is unlikely to be related to lipid accumulation. However,
we found a decrease in the levels of GM1 and GM2 gangliosides in
PGC-1β KO samples which correlates with defective gene expression
of enzymes regulating this pathway. Gangliosides have positive ef-
fects on ER stress activation by promoting calcium ﬂuxes from ER to
mitochondria (Sano, et al., 2009, Tessitore, et al., 2004). While our re-
sults showed gangliosides downregulation, it does not preclude that
GM1 and GM2 species decrease might contribute to chances in calci-
um homeostasis and increase the susceptibility to ER stress activationunder chronic nutritional or pharmacological stimulus. In this scenar-
io, it is tentative to propose that defects in gangliosides synthesis may
alter the ﬂow of the lipids through the metabolic pathways contribut-
ing to disruption in cellular physiology. Supporting our hypothesis, a
decrease in phosphatidylethanolamine species promotes disruption
in calcium homeostasis resulting in hepatic ER stress and insulin re-
sistance in obesity (Fu, et al., 2011). These results suggest that aber-
rant lipid metabolism might increase the susceptibility to calcium
homeostasis and cellular damage, an open question to be addressed
in future research.
Our results also showed that PGC-1β KO neurons seem to be more
vulnerable to apoptotic death, as evidenced by the activation of
caspase 3 and PARP, a classical apoptotic cascade activated during mi-
tochondrial dysfunction (Szegezdi, et al., 2006) induced by either
drugs or nutritional interventions known to activate the ER stress re-
sponse, such as thapsigargin or HFD, respectively. We have shown
that HFD feeding increases brain CHOP protein levels, which is also
an ER stress marker, in PGC-1β KO mice when compared to WT,
suggesting its contribution to activation of apoptotic cell death
under HFD feeding as was reported recently (McNay, et al., 2012),
while more experiments have to be done to support this mechanism.
Altogether, this indicates that mitochondrial defects in PGC-1β KO
neurons appear to increase the susceptibility to neuronal death in-
duced by activation of ER stress response.
405A. Camacho et al. / Experimental Neurology 237 (2012) 396–406The main aim of the present work was to investigate the signalling
defects related to the inefﬁcient ER stress activation in PGC-1β KO
neurons in response to pharmacological or nutritional challenges.
Our data indicate that genetic ablation of PGC-1β is associated with
non-stimulated basal activation of mTORC1, as evidenced by S6K1
(Thr389) phosphorylation but not of Ser235/236 of 40S ribosomal
protein S6, in adult brains. Ser235/236 phosphorylation might be a
downstream target of S6K1 activation (Wullschleger, et al., 2006),
but not necessarily activated by this pathway, as was suggested pre-
viously (Pende, et al., 2004, Ruvinsky, et al., 2005). On the other
hand, the molecular mechanisms leading to the constitutive activa-
tion of mTORC1 pathway in the PGC-1β KO model are unclear.
mTORC1 is typically upregulated by four major anabolic regulatory
inputs: amino acids, growth factors, ATP/AMP ratio and cytoplasmic
calcium (Gulati, et al., 2008, Howell and Manning, 2011). Given that
glucose and amino acids are metabolized in the mitochondria, it can
be hypothesized that basal defects in mitochondria oxidative capacity
in the PGC-1β KO model may lead to cytoplasmic nutrient overload
and may contribute to the activation of mTORC1, particularly under
basal conditions. The potential relevance of this mechanism in the
context of obesity is outlined by the fact that plasma amino acid accu-
mulation and mTOR activation has previously been detected in obese
humans and in vivo animal models of obesity (Felig, et al., 1969,
Newgard, et al., 2009, Tremblay, et al., 2007, Wang, et al., 2011).
Our study demonstrates that the constitutive mTORC1 activation
in the PGC-1β KO mice is associated with increased GRP78 protein
levels under basal non‐stimulated conditions. mTOR has been
shown to have positive effects on translation promoting the ER stress
response (Di Nardo, et al., 2009, Inoki, et al., 2011, Kato, et al., 2012,
Ozcan, et al., 2008). We speculate that mTOR activation induced by
a diet enriched in proteins may exacerbate ER stress in the PGC-1β
KO mice. Our in vitro studies support this hypothesis by showing
that activation of mTOR at low amino acid concentrations (at
5–100 μM L-leucine concentration) in PGC-1β KO neurons lead to
increased GRP78 protein levels. However, ablation of PGC-1β
compromised the induction of GRP78 in response to higher levels of
L-leucine. Similar to the latter response, absence of PGC-1β prevented
the expected upregulation of GRP78 in response to chronic increase in
plasma amino acid availability, such as what happened with HPD
feeding during 14 weeks. While we have not measured the amino
acid concentrations in the samples of PGC-1β KOmice after HPD feed-
ing, a recent study using the same dietary conditions showed a three-
fold increase in plasma L-leucine concentration in mice (Mogami, et
al., 2009). Additionally, our data also indicate that in vitro pharmaco-
logical activation of ER stress by thapsigargin leads to mTOR activa-
tion and induction of GRP78 in WT mice, however, it is defective in
PGC-1β KO neurons. Altogether our data suggest a failure of mTOR ac-
tivation by amino acids or ER stress activators to further upregulate
GRP78 in the brain of PGC-1β KO mice.
Our present results support the notion that the effect of mTOR in-
ducing a full response of GRP78 under stimulated conditions requires
PGC-1β. Together, we could speculate that defects in PGC-1β are as-
sociated with basal unstimulated metabolic stress associated with in-
creased mTOR activation which is able to induce a subtle state of ER
stress. However, under stimulated stress conditions, the induction of
a proper ER stress response requires PGC-1β. The present research
also gives us information to suggest that failure to induce an appro-
priate ER stress response seems to be associated with increased sus-
ceptibility to apoptotic neuronal death and further activation of
mTOR, probably in an attempt to optimise the ER stress response. In
any case, more research is needed to support this hypothesis.
Our in vivo and in vitro data also provide information that failure
to induce GRP78 in the PGC-1β KO mice in response to nutritional
or pharmacological challenges may be preferentially coordinated at
post-transcriptional level. In support of this we found decreased
pIF2a levels in PGC-1β KO brains, both under basal and afterstimulation with ER stress inducers. It is known that the PERK/pIF2a
pathway prevents ER stress by inhibition of protein translation and
by promoting GRP78 synthesis (Eizirik, et al., 2008). The fact that
PGC-1β KO brains have activation of mTORC1/S6K1 pathway coupled
with decrease of the PERK/pIF2a cascade suggests that the basal in-
crease in GRP78 under non‐stimulated conditions is likely to be relat-
ed to an increase in the protein(s) translation and its import to the ER
facilitated by the activation of both mechanisms. In fact, Kato et al.
(2012) demonstrated that mTOR activation promotes ER stress re-
sponse, a molecular mechanism likely to be involved in our in vivo
and in vitro model to explain the full ER stress response induction
under pharmacological or nutritional challenges (using thapsigargin
or HPD, respectively) in PGC-1β KO neurons. To our knowledge, this
is the ﬁrst evidence supporting the role of PGC-1β contributing to
the ER stress response involving mTORC1 core.
In summary, our data indicate that ablation of PGC-1β causes met-
abolic stress leading to a mild ER stress response associated to mTOR
activation. However, PGC-1β is required for a full appropriate ER
stress neuronal response to nutritional and pharmacological stimulus
mediated by mTORC1 activation. Absence of PGC-1β seems to in-
crease the susceptibility to neuronal damage mediated by pharmaco-
logical stressors.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.expneurol.2012.06.031.
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